You are not logged in
Login
Create Account
Meetings
Help
Contact Us
Visit our Twitter
Visit our LinkedIn
Appropriate selection of patients for 1st line monotherapy in advanced or unresectable HCC and treatment management in relation with AEsPre-Meeting Survey
If you wish to view the details for the meeting, then please click the button.
Back to the Meeting Details
1. How many patients (number and approximate percent) with advanced or unresectable HCC do you currently treat with TKI monotherapy?
*
2. On a scale of 1 to 5, how confident are you (with 5 as extremely confident) in understanding the efficacy profile of the VEGFR-TKI monotherapies?
*
1
2
3
4
5
3. On a scale of 1 to 5, how confident are you (with 5 as extremely confident) in understanding the safety profile of the VEGFR-TKI monotherapies?
*
1
2
3
4
5
4. On a scale of 1 to 5, how confident (with 5 as extremely confident) are you in understanding which patients could benefit from VEGFR-TKI monotherapy?
*
1
2
3
4
5
5. On a scale of 1 to 5, how familiar (with 5 as extremely familiar) are you in the management of AEs and adapting the dosing strategy?
*
1
2
3
4
5
6. Do you have any questions for the Faculty you would like them to consider within their opening remarks?
7. Do you have a patient case study you are able to share to be discussed in the breakout sessions? If you select YES then we can discuss over email
*
Yes
No
Email Address
*
Send Feedback
COR2ED develops and implements high quality Independent Medical Education programmes to help improve the health of patients globally.
Bodenackerstrasse 17
4103 Bottmingen
Switzerland
Products
Webinars
Meetings
On Demand
SUPPORT
HELP
CONTACT US
Disclaimer: The material and content contained in the website engage.cor2ed.com is for healthcare professionals only. Although every effort is made to ensure that the material within this website is accurate and timely, it is provided for informational and educational purposes only. The information provided is not intended as a substitute for medical professional help, advice, diagnosis or treatment and may not be applicable to every case or country.
© Copyright 2021 | All Rights Reserved
Cookies
Privacy Policy
map-marker
sign-in
user-plus
linkedin
facebook
pinterest
youtube
rss
twitter
instagram
facebook-blank
rss-blank
linkedin-blank
pinterest
youtube
twitter
instagram
We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept
View Cookie Policy
